These differences in biological behaviour could be attributed to the fact that (1) primary adrenal neuroblastoma is more likely to carry structural DNA distortion, including MYCN amplification [13], and (2) the tumour microenvironment is different [12–14]. The gene discussed is MYCN; the disease is adrenal gland neuroblastoma.